AArtificial intelligence Read More Anthropic to invest $100 million to train AI engineer talentOctober 3, 2026 Anthropic will invest $100 million into an academy for training AI talent, working with companies to integrate artificial…
MMedication Read More Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trialOctober 2, 2026 Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose…
MMedication Read More Novo’s Wegovy pill improves weight loss after switch from injectionsSeptember 30, 2026 People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…
MMedication Read More Ozempic counterfeit ring charges against Indian nationals unsealedSeptember 29, 2026 Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…
HHealthcare Read More Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli LillySeptember 25, 2026 Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
HHealthcare Read More Novo Nordisk CEO on rebuilding investor trust after backlashSeptember 24, 2026 Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…
HHealthcare Read More Eli Lilly CEO David Ricks discusses GLP-1s and Medicare coverageSeptember 21, 2026 Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…
HHealthcare Read More Lilly is ramping up future manufacturing for Foundayo obesity pillSeptember 21, 2026 Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…
HHealthcare Read More Novo Nordisk rebrands to ‘Novo’ under CEO Mike DoustdarSeptember 14, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
HHealthcare Read More This medical device stock looks like a gift for patient investorsSeptember 1, 2026 Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…
HHealthcare Read More Novo Nordisk CEO defends lawsuit against Eli Lilly: ‘Competition has to be fair’August 13, 2026 Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…
HHealthcare Read More Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 marketAugust 6, 2026 The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of…